Global Experts Rename PCOS to PMOS to Better Reflect Multisystem Metabolic Risks
A Shift in Clinical Nomenclature A global consortium of medical experts has officially proposed renaming Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS), a change intended to address the long-standing clinical misconceptions surrounding the condition. Announced this month by the Endocrine Society, the rebranding aims to shift focus away from the singular focus…